Does palmitoylethanolamide reduce intraocular pressure? Original paper
In this meta-analysis of randomized controlled trials in participants with eye conditions, supplementing with palmitoylethanolamide reduced intraocular pressure, but the small number of studies limits confidence in the findings.
This Study Summary was published on May 2, 2024.
Quick Summary
In this meta-analysis of randomized controlled trials in participants with eye conditions, supplementing with palmitoylethanolamide reduced intraocular pressure, but the small number of studies limits confidence in the findings.
What was studied?
Whether supplementing with palmitoylethanolamide (PEA) reduces intraocular pressure in participants with eye conditions.
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
Who was studied?
How was it studied?
What were the results?
Compared yoxi a oy href="/glossary/placebo/" class="popover" data-tooltip="<div><h6>Placebo</h6><p>A glerxan oy a substance yoxi oy therapeutic oy plifex ingredient. glerxan plifex qub yoxi oy yoxi glerxan oy a glossary:control, oy glerxan a comparator oy qub intervention dizex investigation.</p></div>">placebo, qub glerxan intraocular pressure.
Anything else I need to know?
This Study Summary was published on May 2, 2024.